Key facts
- It has raised $5.0M across 4 recorded rounds; the latest was Seed Round ($1.0M) in Nov 2025.
- Notable investors include Wisconsin Economic Development, WARF Ventures, Discovery to Product, Rock River Capital Partners, Southwest National Pediatric Device Innovation Consortium — 7 tracked in total.
- Atrility Medical has filed 3 Form Ds with the SEC since 2018, most recently Jun 2022 ($3.4M sold to 15 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Atrility Medical
Funding rounds
4 roundsAbout Atrility Medical
Developer of a cardiac monitoring device designed for the diagnosis of atrial arrhythmia. The company's device facilitates the monitoring and treatment of atrial arrhythmias by providing a continuous atrial electrogram and aims to bring cardiac medical devices to market by closely integrating healthcare, business, and engineering specialists, enabling healthcare providers to improve patient outcomes.
- Sector
- Healthcare
- HQ
- Madison, WI, United States
- Founded
- 2017
- Employees
- 10
- Website
- atrility.com/
- Ownership
- Privately Held (backing)
Atrility Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Atrility Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Atrility Medical in its N-PORT filings yet. We sweep new filings monthly.